mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
0.0003 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0005 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |